20614-48-6Relevant academic research and scientific papers
Comparison of the reaction of benzylammonium N-methylides with that of benzylsulfonium S-methylides
Nishimura, Tomofumi,Zhang, Chen,Maeda, Yasuhiro,Shirai, Naohiro,Ikeda, Shin-ichi,Sato, Yoshiro
, p. 267 - 272 (1999)
Allylbenzylsulfonium S-methylides 8S and dibenzylsulfonium S-methylides 18S have been generated by the fluoride ion-induced desilylation of S- benzyl-S-[(trimethylsilyl)methyl](alk-2-enyl)sulfonium salts 4S and S- benzyl-S-[(trimethylsilyl)methyl](4-substituted benzyl)sulfonium salts 7S, and the isomerized products are compared with those of the corresponding N- methylides. S-Methylides 8S selectively rearrange toward the allyl groups (path a in Chart 2), whereas rearrangement to the benzyl groups (path b) competitively occurs in N-methylides 8N. Isomerization of S-methylides 18S to S-benzylides 19S and 20S competes with sigmatropic rearrangement to the benzyl groups (paths a and b in Chart 3), whereas the isomerization of N- methylides 18N is not observed.
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
-
, (2017/09/15)
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
